Diálisis con albúmina MARS (Molecular Adsorbent Recirculating System) como puente para el trasplante hepático en insuficiencia hepática fulminante: presentación de 3 casos

• Jorge Contreras B ^[2] ; Jaime Poniachik T ^[2] ; Dan Oksenberg R ^[2] ; Claudia Cortés M ^[1] ; José Miguel Valera M ^[2] ; Alejandro Cotera F ^[1] ; Alejandro Pacheco D ^[1] ; Erico Segovia S ^[1] ; María Eugenia Sanhueza V ^[1] ; Andrés Boltansky B ^[1] ; Jorge Rojas C ^[1] ; Julia Guerrero ^[3] ; Juan Carlos Díaz J ^[1]
  1. [1] Universidad de Chile

     Universidad de Chile

     Santiago, Chile

     
  2. [2] Hospital Clínico universidad de Chile Departamento de Medicina Sección de Gastroenterología
  3. [3] Clínica Alemana de Santiago Unidad de Cuidados Intensivos

  Mostrar afiliaciones +
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 132, Nº. 5, 2004
• Idioma: español
• Títulos paralelos:
  • Albumin dialysis MARS (Molecular Adsorbent Recirculating System) in acute liver failure, before liver transplantation: Report of three cases
• Enlaces
  • Texto completo
• Resumen

  • The most successful therapy for acute liver failure is liver transplantation. However, due to the low number of donors, organ support therapies need to be used as a bridge to liver transplantation. Molecular Adsorbents Recirculating System (MARS) is a dialysis treatment that uses a recirculating dialysate containing albumin. This allows the removal of both hydrosoluble and albumin-related substances. This system improves hepatic encephalopathy, renal dysfunction and some clinical parameters in acute liver failure, but there is no clear decrease in mortality. We report three women aged 23, 21 and 61 years, that were subjected to liver transplantation, in whom this therapy was successfully used (Rev Méd Chile 2004; 132: 601-7).